|
|
||||||||
1 Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK
2 LICR, Experimental Medicine Unit, Université Catholique de Louvain, Brussels, Belgium
3 Department of Biochemistry & Molecular Biology, New Jersey Medical School, Newark, USA
4 Department of Genetics, Harvard Medical School, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA
Correspondence
Geoffrey L. Smith
glsmith{at}imperial.ac.uk
Poxviruses express numerous proteins involved in manipulating the host immune response. Analysis of the primary sequence and predicted structure of the 134R protein of Yaba-like disease virus (Y134R) indicated that it is similar to cellular proteins of the IL-10 family, specifically IL-19, IL-20 and IL-24. A flag-tagged Y134R was expressed from mammalian cells and identified as a secreted, monomeric glycoprotein that stimulated signal transduction from class II cytokine receptors IL-20R
/IL-20R
(IL-20R type1) and IL-22R/IL-20R
(IL-20R type 2). Y134R induced phosphorylation of signal transducers and activators of transcription, their translocation to the nucleus and the induction of reporter gene expression. In contrast, Y134R was unable to induce similar responses from either the IL-22 or IFN-
(IL-28A, IL-28B, IL-29) class II cytokine receptors. To examine the role Y134R plays during a poxvirus infection, a vaccinia virus recombinant expressing Y134R was constructed and tested in a murine intranasal infection model. Compared with control viruses, the virus expressing Y134R had a reduced virulence, manifested by reduced weight loss, signs of illness and virus titres in infected organs. These results demonstrate that Y134R is a new viral member of the IL-10-related cytokine family and that its activity in vivo affects virus virulence.
This article has been cited by other articles:
![]() |
A. S. Fahy, R. H. Clark, E. F. Glyde, and G. L. Smith Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence J. Gen. Virol., October 1, 2008; 89(10): 2377 - 2387. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Najarro, C. Gubser, M. Hollinshead, J. Fox, J. Pease, and G. L. Smith Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. J. Gen. Virol., April 1, 2006; 87(Pt 4): 809 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad Viral strategies for evading antiviral cellular immune responses of the host J. Leukoc. Biol., January 1, 2006; 79(1): 16 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Bartlett, K. Buttigieg, S. V. Kotenko, and G. L. Smith Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model J. Gen. Virol., June 1, 2005; 86(6): 1589 - 1596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |